| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/18/1993 | WO1993004695A1 T cell receptor-based therapy for rheumatoid arthritis |
| 03/18/1993 | WO1993004693A1 Synergistic inhibition of hiv-1 |
| 03/18/1993 | WO1993004692A1 Morphogen-induced modulation of inflammatory response |
| 03/18/1993 | WO1993004587A1 Process for controlling lepidopteran pests |
| 03/18/1993 | WO1993004586A1 Biocidal proteins |
| 03/18/1993 | WO1993002654A3 A method of inducing hemoglobin synthesis in red blood cells and uses therefor |
| 03/18/1993 | WO1992020711A3 Lhrh antagonists and intermediate products |
| 03/18/1993 | WO1992012992A3 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods |
| 03/18/1993 | CA2118695A1 Peptide inhibitors of inflammation mediated by selectins |
| 03/18/1993 | CA2117174A1 Collagen-induced platelet aggregation inhibitor |
| 03/18/1993 | CA2117073A1 Mutated growth factor receptor as a drug and its use for the treatment of cancer |
| 03/18/1993 | CA2117058A1 Topical fibrinogen complex |
| 03/18/1993 | CA2116775A1 Callus-specific promoters |
| 03/18/1993 | CA2116541A1 Biocidal proteins |
| 03/18/1993 | CA2116533A1 Hybrid cytokines |
| 03/18/1993 | CA2116526A1 T cell receptor-based therapy for rheumatoid arthritis |
| 03/18/1993 | CA2116453A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
| 03/18/1993 | CA2116339A1 V.alpha.12.1 t-cell receptor-specific reagents for diagnosing and treating rheumatoid arthritis |
| 03/17/1993 | EP0532466A2 Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use |
| 03/17/1993 | EP0532465A1 Protein fraction for cosmetic and dermatological care of the skin |
| 03/17/1993 | EP0532167A2 Non-A, Non-B Hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems |
| 03/17/1993 | EP0532119A1 Composition comprising collagen fibre |
| 03/17/1993 | EP0532090A2 Cellular immunity vaccines from bacterial toxin-antigen conjugates |
| 03/17/1993 | EP0532043A2 Factor Xa linker DNA |
| 03/17/1993 | EP0532029A1 Purple membrane composition with increased efficiency of holographic diffraction |
| 03/17/1993 | EP0531728A1 HSV gD2 Baculovirus expression system |
| 03/17/1993 | EP0531537A1 Hirudin analogue or salt thereof, production thereof, and anticoagulant containing the same as active ingredient |
| 03/17/1993 | EP0531530A1 Process for producing protein |
| 03/17/1993 | EP0531472A1 Humanized and chimeric monoclonal antibodies |
| 03/17/1993 | EP0531467A1 Polypeptide fraction affording protection to cells against mechanical damage and assay |
| 03/17/1993 | EP0531461A1 Biologically active peptides containing d-2-alkyltryptophan. |
| 03/17/1993 | EP0531442A1 Method for using fibronectin in conjunction with percutaneous transluminal coronary angioplasty |
| 03/17/1993 | EP0531434A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 03/17/1993 | EP0531407A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
| 03/17/1993 | EP0495836B1 Dye transfer inhibition |
| 03/17/1993 | EP0321489B1 Molecular cloning and clones of human b lymphotropic virus (hblv) |
| 03/17/1993 | EP0317641B1 Fused protein containing lymphotoxin |
| 03/16/1993 | US5194605 Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs |
| 03/16/1993 | US5194600 Genes which participate in β-glucan assembly and use thereof |
| 03/16/1993 | US5194596 Production of vascular endothelial cell growth factor |
| 03/16/1993 | US5194595 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 03/16/1993 | US5194592 Monoclonal antibodies to novel polypeptide derivatives of human granulocyte colony stimulating factor |
| 03/16/1993 | US5194591 Isolation of an immunoglobulin rich fracton from whey |
| 03/16/1993 | US5194590 Acellular red blood cell substitute |
| 03/16/1993 | US5194589 Leech protein having anticoagulant and antimetastatic properties |
| 03/16/1993 | US5194587 Malaria-specific DNA sequences, expression products thereof, and the use thereof |
| 03/16/1993 | US5194586 Adult T Cell Leukemia Associated Antigen |
| 03/16/1993 | US5194585 Vasoactive peptides |
| 03/16/1993 | US5194425 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 03/16/1993 | US5194392 Method of determining mimotopes |
| 03/16/1993 | US5194387 Process for the incorporation of DNA molecules into microorganisms with methyl-specific restriction systems |
| 03/16/1993 | US5194384 Cancer vaccine |
| 03/16/1993 | US5194381 Plasmids and DNA coding for proteins |
| 03/16/1993 | US5194376 Diagnosis and treatment of AIDS |
| 03/16/1993 | US5194375 Dna encoding interleukin-7 receptors and methods of use |
| 03/16/1993 | US5194256 Purified human cytomegalovirus protein |
| 03/16/1993 | US5194255 Hypotensive agents from milk |
| 03/16/1993 | CA2064091C Diagnosis for porcine malignant hyperthermia |
| 03/16/1993 | CA1314656C Analogs of gonadoliberin with improved solubility, methods for their preparation, agents containing them and their use |
| 03/16/1993 | CA1314507C Secretion of insulin-like growth factor-i in e. coli |
| 03/16/1993 | CA1314504C Expression of enzymatically active reverse transcriptase |
| 03/16/1993 | CA1314503C Detectable molecules, method of preparation and use |
| 03/14/1993 | CA2078087A1 Hsv gd2 baculovirus expression system |
| 03/13/1993 | CA2077948A1 Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents |
| 03/11/1993 | DE4129901A1 Affinity carrier for fractionation of bio-polymers - comprises polyamide grafted with vinyl monomer carrying coupling side gps. and monomer with non-coupling gps. |
| 03/11/1993 | DE4129533A1 Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs A mutant growth factor receptor as a medicament and its use for treatment of cancer |
| 03/10/1993 | EP0531273A2 Virus resistant plants and method therefore |
| 03/10/1993 | EP0531204A1 Purified enzymatic preparation from chromobacterium violaceum, process to obtain it and its use in the production of alpha, beta-dehydrotryptophanyl peptides |
| 03/10/1993 | EP0531187A1 Yeast promotor and its use |
| 03/10/1993 | EP0531181A1 Highly stable recombinant yeasts for the production of recombinant proteins |
| 03/10/1993 | EP0531080A2 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein |
| 03/10/1993 | EP0530937A1 Collagen-induced platelet aggregation inhibitor |
| 03/10/1993 | EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof |
| 03/10/1993 | EP0489149A4 Probes for detecting mutant p53 |
| 03/10/1993 | EP0406363B1 Method to diagnose amyloidoses specifically and substance therefor |
| 03/10/1993 | EP0341302B1 Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
| 03/10/1993 | EP0315650B1 Purification of recombinant interleukin-1 |
| 03/10/1993 | EP0255825B1 Detection and differentiation of coxiella burnetii in biological fluids |
| 03/10/1993 | CN1069737A Insulin analogs |
| 03/10/1993 | CN1069735A Rapid synthesis and screening of peptide mimetics |
| 03/10/1993 | CA2077277A1 Cellular immunity vaccines from bacterial toxin-antigen conjugates |
| 03/09/1993 | US5192747 Anticoagulant peptides |
| 03/09/1993 | US5192746 Cyclic cell adhesion modulation compounds |
| 03/09/1993 | US5192745 Cyclic anticoagulant peptides |
| 03/09/1993 | US5192744 Thrombospondin |
| 03/09/1993 | US5192694 Anticoagulant, purification by adsorption on support, immunoadsorbent |
| 03/09/1993 | US5192669 Biosynthesis |
| 03/09/1993 | US5192664 Parathyroid hypertensive factor, antibodies and uses thereof |
| 03/09/1993 | US5192538 Stable forms of antigenic Taenia ovis polypeptides |
| 03/09/1993 | US5192264 Methods and apparatus for treating disease states using oxidized lipoproteins |
| 03/09/1993 | CA1314248C Dna probes for identification and detection of campylobacter jejuni and campylobacter coli based on major outer membrane protein gene |
| 03/05/1993 | CA2077322A1 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| 03/04/1993 | WO1993004373A1 Calcium receptor active molecules |
| 03/04/1993 | WO1993004205A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same |
| 03/04/1993 | WO1993004203A1 Screening methods for immunosuppressive agents |
| 03/04/1993 | WO1993004194A1 LABELLED β-AMYLOID PEPTIDE AND ALZHEIMER'S DISEASE DETECTION |
| 03/04/1993 | WO1993004184A1 Dna sequencing with a t7-type gene 6 exonuclease |
| 03/04/1993 | WO1993004177A1 Proteins with insecticidal properties against homopteran insects and their use in plant protection |
| 03/04/1993 | WO1993004176A1 Yeast promoter and use thereof |
| 03/04/1993 | WO1993004175A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |